Bollard Group LLC Eli Lilly & CO Transaction History

Bollard Group LLC

  • $3.54 Billion
  • Q2 2024

A detailed history of Bollard Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bollard Group LLC holds 251,586 shares of LLY stock, worth $223 Million. This represents 6.43% of its overall portfolio holdings.

Number of Shares
251,586
Previous 251,349 0.09%
Holding current value
$223 Million
Previous $196 Million 16.49%
% of portfolio
6.43%
Previous 5.91%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$724.87 - $909.04 $171,794 - $215,442
237 Added 0.09%
251,586 $228 Million
Q1 2024

May 13, 2024
BUY
$592.2 - $792.28 $153,379 - $205,200
259 Added 0.1%
251,349 $196 Million
Q4 2023

Feb 13, 2024
BUY
$525.19 - $619.13 $155,456 - $183,262
296 Added 0.12%
251,090 $146 Million
Q3 2023

Nov 14, 2023
BUY
$434.7 - $599.3 $133,018 - $183,385
306 Added 0.12%
250,794 $135 Million
Q2 2023

Aug 14, 2023
BUY
$350.74 - $468.98 $71,200 - $95,202
203 Added 0.08%
250,488 $117 Million
Q1 2023

May 12, 2023
BUY
$310.63 - $364.82 $170,225 - $199,921
548 Added 0.22%
250,285 $86 Million
Q4 2022

Feb 10, 2023
SELL
$321.55 - $374.67 $2.26 Million - $2.63 Million
-7,016 Reduced 2.73%
249,737 $91.4 Million
Q3 2022

Nov 09, 2022
BUY
$296.48 - $337.87 $59,296 - $67,574
200 Added 0.08%
256,753 $83 Million
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $140,758 - $165,271
505 Added 0.2%
256,553 $83.2 Million
Q1 2022

May 12, 2022
BUY
$234.69 - $291.66 $539,082 - $669,943
2,297 Added 0.91%
256,048 $73.3 Million
Q4 2021

Feb 11, 2022
BUY
$224.85 - $279.04 $167,738 - $208,163
746 Added 0.29%
253,751 $70.1 Million
Q3 2021

Nov 12, 2021
BUY
$221.6 - $272.71 $294,063 - $361,886
1,327 Added 0.53%
253,005 $58.5 Million
Q2 2021

Aug 12, 2021
SELL
$180.55 - $233.54 $3.92 Million - $5.07 Million
-21,690 Reduced 7.93%
251,678 $57.8 Million
Q1 2021

May 11, 2021
SELL
$164.32 - $212.72 $4.04 Million - $5.22 Million
-24,560 Reduced 8.24%
273,368 $51.1 Million
Q4 2020

Feb 04, 2021
SELL
$130.46 - $172.63 $250,352 - $331,276
-1,919 Reduced 0.64%
297,928 $50.3 Million
Q3 2020

Nov 12, 2020
SELL
$146.22 - $169.13 $292 - $338
-2 Reduced -0.0%
299,847 $44.4 Million
Q2 2020

Aug 13, 2020
SELL
$136.42 - $164.18 $973,765 - $1.17 Million
-7,138 Reduced 2.33%
299,849 $49.2 Million
Q1 2020

May 14, 2020
BUY
$119.05 - $147.35 $80,239 - $99,313
674 Added 0.22%
306,987 $42.6 Million
Q4 2019

Feb 10, 2020
BUY
$106.92 - $132.43 $83,504 - $103,427
781 Added 0.26%
306,313 $40.3 Million
Q3 2019

Nov 13, 2019
BUY
$106.79 - $116.16 $88,101 - $95,832
825 Added 0.27%
305,532 $34.2 Million
Q2 2019

Aug 13, 2019
SELL
$110.79 - $129.32 $4.02 Million - $4.7 Million
-36,307 Reduced 10.65%
304,707 $33.8 Million
Q1 2019

May 10, 2019
BUY
$111.31 - $131.02 $142,365 - $167,574
1,279 Added 0.38%
341,014 $44.3 Million
Q4 2018

Feb 05, 2019
BUY
$105.9 - $118.64 $690,150 - $773,176
6,517 Added 1.96%
339,735 $39.3 Million
Q3 2018

Nov 08, 2018
BUY
$85.86 - $107.31 $467,250 - $583,981
5,442 Added 1.66%
333,218 $35.8 Million
Q2 2018

Aug 09, 2018
BUY
$75.7 - $86.88 $223,012 - $255,948
2,946 Added 0.91%
327,776 $28 Million
Q1 2018

May 14, 2018
BUY
$74.21 - $87.6 $310,197 - $366,168
4,180 Added 1.3%
324,830 $25.1 Million
Q4 2017

Jan 29, 2018
BUY
$81.94 - $87.89 $185,757 - $199,246
2,267 Added 0.71%
320,650 $27.1 Million
Q3 2017

Oct 27, 2017
BUY
$77.07 - $85.54 $24.5 Million - $27.2 Million
318,383
318,383 $27.2 Million

Others Institutions Holding LLY

# of Institutions
3,872
Shares Held
751M
Call Options Held
6.34M
Put Options Held
7.97M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email